Related Experiment Video

Updated: Sep 29, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Antagonistic and agonistic effects of quinazoline tyrosine kinase inhibitors on mutant EGF receptor function

R Bruce Montgomery1

  • 1Department of Medicine, Division of Oncology, University of Washington and VA Puget Sound HCS, Seattle, WA 98108, USA. rbmontgo@u.washington.edu

International Journal of Cancer
|September 5, 2002
PubMed

Insights

Quinazoline tyrphostins AG 1478 and AG 1517 inhibit oncogenic EGFRvIII signaling pathways. However, low AG 1478 concentrations paradoxically enhance tumor cell growth and invasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Epidermal Growth Factor Receptor (EGFR) mutations, specifically EGFRvIII, drive tumorigenesis in various human cancers.
  • EGFRvIII's ligand-independent activation of tyrosine kinase activity promotes uncontrolled cell proliferation.
  • Targeting EGFRvIII kinase activity offers a potential therapeutic strategy against tumors expressing this oncogenic variant.

Purpose of the Study:

  • To investigate the efficacy of quinazoline tyrphostins AG 1478 and AG 1517 in inhibiting EGFRvIII.
  • To elucidate the molecular mechanisms by which these inhibitors affect EGFRvIII signaling pathways.
  • To assess the impact of these inhibitors on cancer cell transformation and invasive properties.

Main Methods:

  • Treatment of cell lines expressing EGFRvIII with quinazoline tyrphostins AG 1478 and AG 1517.
  • Analysis of EGFRvIII autophosphorylation, MAP kinase signaling, and Grb2/SOS association.
  • Assessment of receptor dimerization, phosphotyrosine content, colony formation in soft agar, and matrigel invasion.

Main Results:

  • AG 1478 and AG 1517 suppressed EGFRvIII-mediated morphologic transformation and inhibited receptor autophosphorylation and MAP kinase signaling.
  • Minimal effects were observed on EGFRvIII association with Grb2/SOS.
  • Low concentrations of AG 1478 increased EGFRvIII dimerization and phosphotyrosine content, leading to enhanced colony formation and invasion.

Conclusions:

  • Quinazoline tyrphostins AG 1478 and AG 1517 effectively inhibit key EGFRvIII signaling pathways.
  • Paradoxical effects of low-dose AG 1478, including enhanced colony formation and invasion, highlight complex signaling modulation and potential therapeutic challenges.
  • Further research is needed to optimize EGFRvIII inhibition strategies, considering dose-dependent effects on receptor dimerization and downstream signaling.

More Related Videos

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...